Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Isoprenaline hydrochloride |
Is a |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Accidental overdose of isoprenaline |
Causative agent (attribute) |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Allergy to isoprenaline |
Causative agent (attribute) |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Oral isoprenaline allergy |
Causative agent (attribute) |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Inhaled isoprenaline allergy |
Causative agent (attribute) |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Parenteral isoprenaline allergy |
Causative agent (attribute) |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Isoprenaline overdose |
Causative agent (attribute) |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Intentional overdose of isoprenaline (disorder) |
Causative agent (attribute) |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
surdose d'isoprénaline d'intention indéterminée |
Causative agent (attribute) |
False |
Isoprenaline |
Inferred relationship |
Some |
1 |
chlorhydrate d'isoprénaline 2 mg/2 mL, concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Isoprenaline sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Product containing isoprenaline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Inhaled isoproterenol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Isoprenaline-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Product containing isoprenaline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Isoprenaline sulfate |
Is a |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Isoproterenol hydrochloride 1:5000mg injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Isoproterenol hydrochloride 1:50,000mg(0.2mg/mL) injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Isoproterenol hydrochloride 1:50,000mg(0.2mg/mL) injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Isoproterenol hydrochloride 1:5000mg injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Isoproterenol hydrochloride 1:5000mg injection solution 125mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Isoproterenol hydrochloride 1:50,000mg(0.2mg/mL) injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Isoproterenol hydrochloride 1:5000mg injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Isoprenaline adverse reaction |
Causative agent (attribute) |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Oral isoprenaline adverse reaction |
Causative agent (attribute) |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Inhaled isoprenaline adverse reaction |
Causative agent (attribute) |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Parenteral isoprenaline adverse reaction |
Causative agent (attribute) |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Sodium cromoglycate+isoprenaline sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Isoprenaline |
Inferred relationship |
Some |
|
Oral isoprenaline allergy |
Causative agent (attribute) |
False |
Isoprenaline |
Inferred relationship |
Some |
1 |
Allergy to isoprenaline |
Causative agent (attribute) |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Parenteral isoprenaline allergy |
Causative agent (attribute) |
False |
Isoprenaline |
Inferred relationship |
Some |
1 |
Inhaled isoprenaline allergy |
Causative agent (attribute) |
False |
Isoprenaline |
Inferred relationship |
Some |
1 |
Isoprenaline hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Isoprenaline |
Inferred relationship |
Some |
|
Isoprenaline sulfate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Isoprenaline |
Inferred relationship |
Some |
|
Product containing cromoglicic acid and isoprenaline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoprenaline |
Inferred relationship |
Some |
2 |
Cromoglicic acid and isoprenaline only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoprenaline |
Inferred relationship |
Some |
2 |
Product containing only isoprenaline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Product containing only isoprenaline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |
Product containing only isoprenaline in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Isoprenaline |
Inferred relationship |
Some |
1 |